MARCHINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 13.754
EU - Europa 7.040
AS - Asia 4.661
SA - Sud America 516
Continente sconosciuto - Info sul continente non disponibili 364
AF - Africa 176
OC - Oceania 13
AN - Antartide 1
Totale 26.525
Nazione #
US - Stati Uniti d'America 13.223
CN - Cina 1.856
IT - Italia 1.528
SG - Singapore 1.373
RU - Federazione Russa 1.355
PL - Polonia 1.307
DE - Germania 791
GB - Regno Unito 444
BR - Brasile 419
CA - Canada 419
FR - Francia 375
VN - Vietnam 365
HK - Hong Kong 353
UA - Ucraina 339
SE - Svezia 310
FI - Finlandia 241
TR - Turchia 145
KR - Corea 135
ZA - Sudafrica 123
IN - India 109
IE - Irlanda 79
BD - Bangladesh 51
MX - Messico 51
NL - Olanda 49
AR - Argentina 39
JP - Giappone 39
BE - Belgio 36
AT - Austria 35
ES - Italia 34
PK - Pakistan 30
CZ - Repubblica Ceca 27
EU - Europa 26
IR - Iran 22
RO - Romania 17
AE - Emirati Arabi Uniti 16
EG - Egitto 16
HN - Honduras 16
IQ - Iraq 16
BH - Bahrain 15
LT - Lituania 15
MY - Malesia 15
EC - Ecuador 14
ID - Indonesia 13
UZ - Uzbekistan 12
VE - Venezuela 12
TW - Taiwan 11
AU - Australia 9
CL - Cile 9
IL - Israele 9
KE - Kenya 9
CO - Colombia 8
JM - Giamaica 8
KZ - Kazakistan 8
PH - Filippine 8
SA - Arabia Saudita 8
CR - Costa Rica 7
JO - Giordania 7
PT - Portogallo 7
AZ - Azerbaigian 6
MA - Marocco 6
NP - Nepal 6
RS - Serbia 6
TH - Thailandia 6
BB - Barbados 5
CH - Svizzera 5
EE - Estonia 5
KG - Kirghizistan 5
PY - Paraguay 5
TT - Trinidad e Tobago 5
AL - Albania 4
BG - Bulgaria 4
BY - Bielorussia 4
DK - Danimarca 4
LV - Lettonia 4
OM - Oman 4
PE - Perù 4
PR - Porto Rico 4
SI - Slovenia 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
HU - Ungheria 3
MD - Moldavia 3
ML - Mali 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
UY - Uruguay 3
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
LB - Libano 2
LK - Sri Lanka 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
Totale 26.164
Città #
Ashburn 1.191
Warsaw 1.152
Fairfield 992
Woodbridge 961
Jacksonville 815
San Jose 811
Singapore 687
Houston 668
Chandler 601
Ann Arbor 508
Council Bluffs 479
Wilmington 474
Seattle 466
Cambridge 358
Hong Kong 344
Boardman 332
Camerino 298
Nanjing 278
Beijing 262
New York 228
Toronto 220
Los Angeles 198
The Dalles 196
Dallas 184
Kraków 146
Dearborn 130
Seoul 128
San Mateo 126
Tongling 122
Chicago 119
Helsinki 117
Johannesburg 113
Lauterbourg 112
Princeton 108
Lawrence 106
Columbus 102
Istanbul 101
Ho Chi Minh City 100
London 98
Nanchang 98
Ogden 94
Buffalo 83
Düsseldorf 83
Santa Clara 83
Dublin 79
Moscow 77
Hanoi 75
Lachine 72
Milan 72
São Paulo 64
Kunming 63
Phoenix 61
Shanghai 60
Shenyang 57
Rome 51
Dong Ket 50
San Diego 48
Centro 47
Montreal 47
Tianjin 47
Guangzhou 46
Hebei 45
Orem 45
Munich 44
Jinan 42
Brooklyn 41
Jiaxing 41
Denver 35
Hefei 35
St Louis 35
Tokyo 35
Brussels 34
Verona 32
Falls Church 31
Changsha 30
Hangzhou 30
Zhengzhou 30
Atlanta 28
Venezia 28
Vienna 28
Redwood City 26
Trieste 25
Valle 25
Chennai 24
Philadelphia 24
San Francisco 24
Bologna 23
Ningbo 23
Da Nang 22
Athens 19
Brno 19
Wuhan 19
Mumbai 18
Redondo Beach 18
Amsterdam 17
Napoli 17
Washington 17
Avellino 16
Boston 16
Jinhua 16
Totale 16.965
Nome #
Antioxidant and antiproliferative activities of different varieties of cauliflower (Brassica oleracea var. botrytis) after cooking processes. 504
Personalized liposome–protein corona in the blood of breast, gastric and pancreatic cancer patients 462
Complessi di rutenio con attività chemioterapica antitumorale 442
In vivo protein corona patterns of lipid nanoparticles 415
The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery 377
VirF Relieves the Transcriptional Attenuation of the Virulence Gene icsA of Shigella flexneri Affecting the icsA mRNA-RnaG Complex Formation 354
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition 345
The water soluble ruthenium(II) organometallic compound[Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Clsuppresses triple negative breast cancer growth by inhibiting tumorinfiltration of regulatory T cells 344
Resveratrol fuels HER2 and ERα‐positive breast cancer behaving as proteasome inhibitor 337
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 333
Aspirin modulates LPS-induced nitric oxide release in rat glial cells 331
Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells 304
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 301
Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer 298
A novel 39-tRNAGlu-derived fragment acts as a tumor-suppressor in breast cancer by targeting nucleolin 284
HER2-Driven carcinogenesis: new mouse models for novel immunotherapies 280
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 279
Tailoring DNA vaccines: designing strategies against HER2-positive cancers 279
Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD) 278
Cholesterol dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO Living Cells 274
Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer. 274
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 271
Azolate/phosphane Gold(I) compounds in antiproliferative therapy: a new frontier for the azolate gold(I) chemistry 270
Tumor vessel compression hinders perfusion of ultrasonographic contrast agents 269
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2- positive breast carcinomas resistant to Lapatinib 267
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer 265
Azolate gold(I) phosphane complexes as innovative therapies for the treatment of HER2-driven breast cancer 264
Combination of Coenzyme Q10 intake and moderate physical activity counteracts mitochondrial dysfunctions in a SAMP8 mouse model Oxidative Medicine and Cellular Longevity. 264
Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling 263
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 259
Cyclooxygenase-2 (COX2) gene silencing with siRNA could enhance DNA vaccination to inhibit established ErbB-2 carcinomas 256
NANOPARTICELLE LIPIDICHE MULTICOMPONENTI E PROCEDIMENTI PER LA LORO PREPARAZIONE 255
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells 251
IN VITRO AND IN VIVO STUDIES FOR THE TREATMENT OF BASAL LIKE BREAST CANCER (BLBC) WITH AZOLATE/PHOSPHANE GOLD(I) COMPOUNDS 249
Factors Determining the Superior Performance of Lipid/DNA/Protammine Nanoparticles over Lipoplexes. 248
Structure-function relationships in bovine thymus 20S proteasome: a fluorimetric study 245
Getting the most from gene delivery by repeated DNA transfections 245
Role of temperature-independent lipoplex-cell membrane interactions in the efficiency boost of multicomponent lipoplexes. 240
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 239
Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients 235
Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition 233
Characterization of an inwardly rectifying chloride conductance expressed by cultured rat cortical astrocytes. 232
Toward the Rational Design of Lipid Gene Vectors: Shape Coupling between Lipoplex and Anionic Cellular Lipids Controls the Phase Evolution of Lipoplexes and the Efficiency of DNA Release 231
Tailoring lipoplex composition to the lipid composition of plasma membrane: a Trojan horse for cell entry? 230
Vaccination trials against bovine herpesvirus-1 227
Transfection efficiency boost by designer multicomponent lipoplexes 223
Ruthenium Complexes with Antitumoral Chemiotherapy Activites 223
Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells 222
Antiproliferative Activity of a New (Arene)Ruthenium(II) Complex on a Model of Breast Cancer 221
CCL16 enhances the CD8+ and CD4+ T cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2 220
Transfection efficiency boost of cholesterol-containing lipoplexes 220
Costrutto di acido nucleico, vettore e vaccino a DNA includenti detto costrutto 218
Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules 217
Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity 213
Characterization of two voltage-dependent, inwardly rectifying currents in dibutyryl-cyclic AMP treated cortical astrocytes 212
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 211
Enhanced transfection efficiency of multicomponent lipoplexes in the regime of optimal membrane charge density 211
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 208
On the correlation between phase evolution of lipoplexes/anionic lipid mixtures and DNA release 206
Protective mechanisms of adenosine in neurons and glial cells. 206
The Second Ascoli Piceno Conference on Gene Vacciantion in Cancer, October 9-11 2013 205
DNA release from cationic liposome/DNA complexes by anionic lipids 204
Efficient escape from endosomes determines the superior efficiency of multicomponent lipoplexes 203
Surface adsorption of protein corona controls the cell uptake mechanism in efficient cationic liposome/DNA complexes in serum. 202
LIBRERIA FAGICA DI FRAMMENTI DELLA PROTEINA HER2 202
Homeostatic effects of adenosine on potentially neurotoxic glial cell activation. 201
Novel Mechanisms of Cell Uptake in Lipid-Mediated Gene Delivery 201
Cascading glial reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. 201
Indoleamine 2,3-Dioxygenase (IDO) silencing for improved antitumour vaccination 198
p185neu encoding DNA and therapeuticaluses thereof 197
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 196
Cationic lipid/DNA complexes manufactured by microfluidics and bulk self-assembly exhibit different transfection behavior 195
P185neu-encoding DNA and therapeutical uses thereof 193
Two distinct inwardly rectifying conductances are expressed in long term dibutyryl-cyclic-AMP treated rat cultured cortical astrocytes. 192
Surface area of lipid membranes regulates the DNA-binding capacity of cationic liposomes. 192
Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A 192
Mechanistic Understanding of Gene Delivery Mediated by Highly Efficient Multicomponent Envelope-Type Nanoparticle Systems 191
Glia-related pathomechanisms in Alzheimer' s disease: a therapeutic target? 188
Effects of a supplementation with tart cherry (Prunus cerasus L.) juice and its kernel extract on antioxidant status and muscle health 187
Self-assembled ternary complexes of neutral liposomes, DNA and bivalent metal cations. Promising vectors for gene transfer? 183
Programmed packaging of multicomponent envelope-type nanoparticle system for gene delivery. 182
Effect of pH on the structure of lipoplexes 181
Structural stability and increase in size rationalize the efficiency of lipoplexes in serum. 180
Efficient Delivery of DNA Using Lipid Nanoparticles 179
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 176
Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes 173
p185neu-Encoding DNA and therapeutical uses thereof 170
Programmed packaging of multicomponent envelope-type nanoparticle system (MENS). 170
DNA codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici 169
DNA codificante p185neu e suoi usi terapeutici 167
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favors early tumor growth in syngeneic mice. 166
A Study of Bioactivities and Composition of a Cocktail of Supernatants Derived from Lactic Acid Bacteria for Potential Food Applications 165
Mesenchymal/stromal gene expression signature relates to Basal-like breast cancers, identify bone metastasis and predicts resistance to therapies. 165
Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth 163
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 159
Stathmin is required for normal mouse mammary gland development and Δ16HER2-driven tumorigenesis 159
Structural stability against disintegration by anionic lipids rationalizes the efficency of cationic liposom/DNA complexes 157
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 152
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 149
Different expression of membrane conductances in cultured rat cortical astrocytes induced by intracellular cyclic-AMP elevation 147
Totale 23.586
Categoria #
all - tutte 101.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022921 0 0 0 60 95 84 52 96 128 117 154 135
2022/20231.653 172 43 88 214 171 239 10 140 300 103 124 49
2023/20241.224 158 75 82 42 55 138 46 40 139 41 26 382
2024/20253.941 145 69 292 153 133 184 520 1.019 318 300 225 583
2025/20265.664 407 339 432 810 616 441 968 442 240 411 369 189
2026/20271.844 366 266 482 730 0 0 0 0 0 0 0 0
Totale 26.525